FA
YTEN

FCG Advisors’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

FCG Advisors’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5
Closed -$16K – 152
2017
Q1 		$16K Hold
5
– – 0.01% 120
2016
Q4 		$15K Sell
5
-7
-58% -$26.9K 0.01% 108
2016
Q3 		$54K Buy
12
+4
+50% +$20.3K 0.02% 117
2016
Q2 		$68K Sell
8
-4
-33% -$45.1K 0.02% 130
2016
Q1 		$228K Buy
12
+1
+9% +$14.8K 0.08% 85
2015
Q4 		$157K Sell
11
-1
-8% -$20.2K 0.09% 79
2015
Q3 		$115K Buy
12
+3
+33% +$77K 0.09% 77
2015
Q2 		$312K Sell
9
-4
-31% -$165K 0.25% 64
2015
Q1 		$454K Hold
13
– – 0.23% 66
2014
Q4 		$305K Buy
13
+4
+44% +$137K 0.15% 87
2014
Q3 		$579K Sell
9
-2
-18% -$86.4K 0.38% 40
2014
Q2 		$633K Sell
11
-2
-15% -$113K 0.48% 43
2014
Q1 		$1.01M Hold
13
– – 0.72% 35
2013
Q4 		$959K Buy
13
+6
+86% +$402K 0.65% 34
2013
Q3 		$543K Hold
7
– – 0.39% 41
2013
Q2 		$572K Buy
+7
New +$677K 0.46% 38

Other funds holding YTEN

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

FCG Advisors's YTEN Position: Q2 2017 in Review

FCG Advisors sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2017, closing a stake of 5 shares — an estimated $16K sold.

FCG Advisors first reported a position in YTEN in Q2 2013 and held it in 16 quarters. The position peaked at $1.01M in Q1 2014. 5 funds tracked by Wall St. Rank hold YTEN as of Q2 2017.

  • FCG Advisors reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • FCG Advisors sold 5 Yield10 Bioscience, Inc. Common Stock shares in Q2 2017, an estimated $16K.
  • FCG Advisors first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • FCG Advisors's Yield10 Bioscience, Inc. Common Stock position peaked at $1.01M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2017.

Based on FCG Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.